With the University of Tennessee Health Science Center preparing to build a state-of-the-art pharmaceutical manufacturing facility on campus it’s easy to see why the university’s executive vice chancellor and chief operations officer has such an abiding interest in pharmaceutical safety.
UTHSC is now recruiting participants for the Glycemia Reduction Approaches in Diabetes: A Comparative Effectiveness (GRADE) Study.
A $1.5 million grant from the National Institute of Diabetes and Digestive and Kidney Diseases will allow Dr. Adebowale Adebiyi to further investigate newborn kidney function. Adebiyi is an assistant professor in the Department of Physiology at the University of Tennessee Health Science Center (UTHSC). With the grant he will focus on the functions of cell… Read More
